230 related articles for article (PubMed ID: 38674026)
1. Potential Diagnostic and Clinical Significance of Selected Genetic Alterations in Glioblastoma.
Tomoszková S; Škarda J; Lipina R
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674026
[TBL] [Abstract][Full Text] [Related]
2. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.
Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X
J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962
[TBL] [Abstract][Full Text] [Related]
3. EGFR amplification is a real independent prognostic impact factor between young adults and adults over 45yo with wild-type glioblastoma?
Armocida D; Pesce A; Frati A; Santoro A; Salvati M
J Neurooncol; 2020 Jan; 146(2):275-284. PubMed ID: 31889239
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and Therapeutic Biomarkers in Glioblastoma: Current Status and Future Perspectives.
Szopa W; Burley TA; Kramer-Marek G; Kaspera W
Biomed Res Int; 2017; 2017():8013575. PubMed ID: 28316990
[TBL] [Abstract][Full Text] [Related]
5. The TERT promoter mutation status and MGMT promoter methylation status, combined with dichotomized MRI-derived and clinical features, predict adult primary glioblastoma survival.
Shu C; Wang Q; Yan X; Wang J
Cancer Med; 2018 Aug; 7(8):3704-3712. PubMed ID: 29984907
[TBL] [Abstract][Full Text] [Related]
6. Molecular subtyping of glioblastoma based on immune-related genes for prognosis.
Chen X; Fan X; Zhao C; Zhao Z; Hu L; Wang D; Wang R; Fang Z
Sci Rep; 2020 Sep; 10(1):15495. PubMed ID: 32968155
[TBL] [Abstract][Full Text] [Related]
7. A novel gene signature based on five glioblastoma stem-like cell relevant genes predicts the survival of primary glioblastoma.
Chai R; Zhang K; Wang K; Li G; Huang R; Zhao Z; Liu Y; Chen J
J Cancer Res Clin Oncol; 2018 Mar; 144(3):439-447. PubMed ID: 29299749
[TBL] [Abstract][Full Text] [Related]
8. Expression and clinical significance of CPS1 in glioblastoma multiforme.
Wu G; Yan Y; Zhou Y; Wang X; Wei J; Chen X; Lin W; Ou C; Zhou J; Xu Z
Curr Res Transl Med; 2019 Nov; 67(4):123-128. PubMed ID: 31492588
[TBL] [Abstract][Full Text] [Related]
9. Integrated analysis of 34 microarray datasets reveals CBX3 as a diagnostic and prognostic biomarker in glioblastoma.
Wang S; Liu F; Wang Y; Fan W; Zhao H; Liu L; Cen C; Jiang X; Sun M; Han P
J Transl Med; 2019 May; 17(1):179. PubMed ID: 31138312
[TBL] [Abstract][Full Text] [Related]
10. Prognostic quality of activating TERT promoter mutations in glioblastoma: interaction with the rs2853669 polymorphism and patient age at diagnosis.
Spiegl-Kreinecker S; Lötsch D; Ghanim B; Pirker C; Mohr T; Laaber M; Weis S; Olschowski A; Webersinke G; Pichler J; Berger W
Neuro Oncol; 2015 Sep; 17(9):1231-40. PubMed ID: 25681309
[TBL] [Abstract][Full Text] [Related]
11. Genetic and clinical characteristics of primary and secondary glioblastoma is associated with differential molecular subtype distribution.
Li R; Li H; Yan W; Yang P; Bao Z; Zhang C; Jiang T; You Y
Oncotarget; 2015 Mar; 6(9):7318-24. PubMed ID: 25821160
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics analysis of potential core genes for glioblastoma.
Zhang Y; Yang X; Zhu XL; Hao JQ; Bai H; Xiao YC; Wang ZZ; Hao CY; Duan HB
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32667033
[TBL] [Abstract][Full Text] [Related]
13. Surgical outcome and molecular pattern characterization of recurrent glioblastoma multiforme: A single-center retrospective series.
Montemurro N; Fanelli GN; Scatena C; Ortenzi V; Pasqualetti F; Mazzanti CM; Morganti R; Paiar F; Naccarato AG; Perrini P
Clin Neurol Neurosurg; 2021 Aug; 207():106735. PubMed ID: 34119900
[TBL] [Abstract][Full Text] [Related]
14. Genomic landscape of gliosarcoma: distinguishing features and targetable alterations.
Zaki MM; Mashouf LA; Woodward E; Langat P; Gupta S; Dunn IF; Wen PY; Nahed BV; Bi WL
Sci Rep; 2021 Sep; 11(1):18009. PubMed ID: 34504233
[TBL] [Abstract][Full Text] [Related]
15. Hub biomarkers for the diagnosis and treatment of glioblastoma based on microarray technology.
Cui K; Chen JH; Zou YF; Zhang SY; Wu B; Jing K; Li LW; Xia L; Sun C; Dong YL
Technol Cancer Res Treat; 2021; 20():1533033821990368. PubMed ID: 34018447
[TBL] [Abstract][Full Text] [Related]
16. A novel literature-based approach to identify genetic and molecular predictors of survival in glioblastoma multiforme: Analysis of 14,678 patients using systematic review and meta-analytical tools.
Thuy MN; Kam JK; Lee GC; Tao PL; Ling DQ; Cheng M; Goh SK; Papachristos AJ; Shukla L; Wall KL; Smoll NR; Jones JJ; Gikenye N; Soh B; Moffat B; Johnson N; Drummond KJ
J Clin Neurosci; 2015 May; 22(5):785-99. PubMed ID: 25698544
[TBL] [Abstract][Full Text] [Related]
17. Do Long-Term Survivor Primary Glioblastoma Patients Harbor IDH1 Mutations?
Sarmiento JM; Mukherjee D; Black KL; Fan X; Hu JL; Nuno MA; Patil CG
J Neurol Surg A Cent Eur Neurosurg; 2016 May; 77(3):195-200. PubMed ID: 26935296
[TBL] [Abstract][Full Text] [Related]
18. Additional genetic alterations in BRAF-mutant gliomas correlate with histologic diagnoses.
Dono A; Vu J; Anapolsky M; Hines G; Takayasu T; Yan Y; Tandon N; Zhu JJ; Bhattacharjee MB; Esquenazi Y; Ballester LY
J Neurooncol; 2020 Sep; 149(3):463-472. PubMed ID: 33009979
[TBL] [Abstract][Full Text] [Related]
19. Liquid Biopsy in Glioblastoma Management: From Current Research to Future Perspectives.
Gatto L; Franceschi E; Di Nunno V; Tosoni A; Lodi R; Brandes AA
Oncologist; 2021 Oct; 26(10):865-878. PubMed ID: 34105205
[TBL] [Abstract][Full Text] [Related]
20. Recent advances of the regulation roles of MicroRNA in glioblastoma.
Yan C; Kong X; Gong S; Liu F; Zhao Y
Int J Clin Oncol; 2020 Jul; 25(7):1215-1222. PubMed ID: 32347433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]